Agenda at a Glance

Day One, Wednesday, April 20, 2005
8:00-9:00	Conference Registration & Morning Coffee
9:00-9:30	OPENING ADDRESS AND WELCOME: Examining the academic and industrial infrastructure of Ireland and how it supports the commercial development of nanotechnology within industry Dr. Feargal Ó Móráin, (Chairman) Executive Director Science & Innovation, Enterprise Ireland
9:30-10:00	KEYNOTE ADDRESS: Analyzing the financial markets and nanotechnology: When will IPOs of nanotechnology become common place and what will this mean for the commercial development of nanotechnology? Pete Conley, Managing Partner, Analytiq Group
10:30-11:00	Coffee and Networking Break
11:00:-11:45	Executive Panel The Future of Nanotechnology in Industry and the Trend of Nanotechnology in Europe MODERATOR: Dr. Andrew Dunn, Senior Analyst, Cientifica PANELISTS: ·          Dr. Uwe Albrecht , Head of Corporate Fund, Siemens Venture Capital GmbH ·          Dr. Erich Ruetsche, Manager, Business Development  & Relations, IBM Zurich Research ·          Dr. Stephan Altmann, Polymer Physics, BASF AG •       Dr. Susanne Arney, Director, Microsystems and Nanotechnology Research, Bell Labs Lucent Technologies (USA) ·          Dr. John Magan, Assistant Director, European Commission - Information Society & Media Directorate General – INFSO (Belgium)
11:45-12:30	Executive Panel Nanotech Safety & Toxicology MODERATOR: Dr. Andrew Dunn, Senior Analyst, Cientifica Ltd. PANELISTS: ·          Dr. Rodger Duffin, Particle Toxicologist, Centre for Inflammation Research, University of Edinburgh ·          Dr. Bart Gremmen, Professor, Wageningen Agricultural University
12:30-1:30	Luncheon for Delegates
Breakout Sessions	Track A: ELECTRONICS	Track B : PHARMACEUTICAL & MEDICAL	Track C : NANOTECHNOLOGY & SMES
	CHAIRPERSON: Dr. Jens Greiser, Strategic Marketing Manager, FEI Company	CHAIRPERSON: (tbd)	CHAIRPERSON: (tbd)
1:30-2:05	Nanotechnology and Displays Dr. Dave Corr, Chief Technology Officer, NTera	Nanotechnology for Drug and Vaccine Delivery Gary Liversidge, Senior Director, Project Planning and Management, Elan Corporation	Case Study: Integrating Nanotechnology into an SME Business Dr. Joerg Wiesmann, Managing Director, Incoatec GmbH
2:05-2:40	Nanotechnology and Data Storage Dr. Sining Mao, R/D Director of Advanced Devices Development, Seagate	Nanotechnology for Antibacterial applications Robert Kwan, CEO, JR Nanotech	Partnering & Collaboration:  Identifying when and with whom partnering makes sense Dr. Jake Reder, Manager of New Business Development, Cabot Corporation
2:40-3:10	Refreshment Break and Opportunity to Visit Exhibit Hall
3:10-3:45	Transitioning from Microelectronics to Nanostructural Electronics: Novel Approaches for Process Control Dr. Anantha Sethuraman, Vice President of Product Marketing, FEI Company	Nanotechnology for Medical Diagnostics and Analysis Kevin Matthews, CEO, Oxonica	Funding: Examining various funding alternatives for funding nanotechnology initiatives from government to private equity Dr. Martin Lyes, Head of Programmes & Directorate, Enterprise Ireland
3:45-4:20	Silicon Nanoelectronics--Innovation Challencges Ahead Dr. Jenny Patterson, Nanotechnology Program Manager, Intel Ireland Ltd.	Nanotechnology for Medical Devices and Biomaterial applications Michael Weiner, President and CEO, Biophan	Infrastructure: Identifying and establishing supplier/buyer relationships Justin Hall-Tipping, Founding Partner, NanoHoldings LLC
4:20-5:00	PANEL FORUM Transforming the ICT Sector: How will the applications of nanotechnology within the electronics industry transform its products Jens Greiser, Strategic Marketing Manager, FEI Company      Dr. Dave Corr, Chief Technology Officer, NTera Dr. Sining Mao, R/D Director of Advanced Devices Development, Seagate Dr. Jenny Patterson, Nanotechnology Program Manager, Intel Ireland Ltd. Handol Kim, Vice President of Business Development, D-Wave Systems Inc.	PANEL FORUM Determining how the applications of nanotechnology within the medical & pharmaceutical industry will transform healthcare in the future: How will  nanotechnology improve medical care and quality of life? Gary Liversidge, Senior Director, Project Planning and Management, Elan Kevin Matthews, CEO, Oxonica Michael Weiner, President and CEO, Biophan Robert Kwan, CEO, JR Nanotech	PANEL FORUM Determining the ROI and impact of integrating nanotechnology into your SME over the next five years: Can adopting nanotechnology into your business be beneficial in the short-term as well as the long-term? Dr. Joerg Wiesmann, Managing Director, Incoatec GmbH Dr. Jake Reder, Manager of New Business Development, Cabot Corporation Dr. Martin Lyes, Head of Programmes & Directorate, Enterprise Ireland Justin Hall-Tipping, Founding Partner, NanoHoldings LLC